DNA barcoding to identify and authenticate botanical ingredients in dietary supplements should only be used in addition to other existing analytical methods, says a new expert review.
Having a crisis communications plan in place to deal with allegations of financial impropriety is a must for a public company, as ChromaDex Corp recently learned to its chagrin.
The botanical raw material GMP proposal put forward by GNC earlier this year is in active revision, according the American Herbal Products Association.
A moribund Massachusetts bill that would have restricted the sale of certain dietary supplements is part and parcel of a rising tide of state bills that affect the industry, according to CRN.
A bill that would have set into stone onerous requirements on dietary supplements in Puerto Rico has been set aside, and two trade associations are taking credit for helping to avert the threat.
Is the dietary supplement industry getting a handle on the adulteration issue? The baseline data does not exist to be able to say one way or another. But sources agree that in the one thing you can measure—the attention the issue is getting—the situation...
Schneiderman, McCaskill, Cohen, Frontline… it’s been blow after blow for the dietary supplements industry, so you have to ask if consumer confidence and trust in the products have been affected.
Transparency has become a watchword among dietary supplement companies. Jim Emme, president of NOW Foods, said it is one of the founding principles of his company.
The New York Attorney General’s Office believes DNA barcoding is still critical for testing herbal supplements, despite new studies showing the inadequacies of the technology.
Two new studies have shown what many in industry have been claiming for a long time: DNA barcoding by itself is not an adequate method for analyzing botanical dietary supplements.
Scott Bass, partner, Sidley Austin LLP, and Steve Mister, President & CEO of the Council for Responsible Nutrition (CRN), will co-chair the Fourth Annual Legal, Regulatory, and Compliance Forum on Dietary Supplements.
Trying to solve the supply chain issues facing the dietary supplement industry is complicated by the muddled state of documentation practices, but there are efforts underway to address the problem.
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
Three of the trade organizations representing the dietary supplement business came together in Utah this week to lend support to plans to extend the industry’s self regulation capabilities.
